Načítá se...
ANXIOSELECTIVE ANXIOLYTICS: ON A QUEST FOR THE HOLY GRAIL
The discovery of “benzodiazepine receptors” provided the impetus to discover and develop anxioselective anxiolytics (“Valium(®) without the side effects”). The market potential for a GABA(A) receptor-based anxioselective resulted in multiple compounds entering clinical trials. In contrast to the anx...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3482271/ https://ncbi.nlm.nih.gov/pubmed/22981367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2012.08.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|